Cardiovascular clinical trials in the era of a pandemic

COVID‐19 has reached pandemic levels in March 2020 and impacted public health with unpredictable consequences.(1, 2) The conduct of clinical research in areas unrelated to COVID‐19 has been disrupted and will be further affected. Researchers, trial participants and study personnel have to overcome c...

Descripción completa

Detalles Bibliográficos
Autores principales: Siontis, George CM, Sweda, Romy, Windecker, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763388/
https://www.ncbi.nlm.nih.gov/pubmed/32993467
http://dx.doi.org/10.1161/JAHA.120.018288
Descripción
Sumario:COVID‐19 has reached pandemic levels in March 2020 and impacted public health with unpredictable consequences.(1, 2) The conduct of clinical research in areas unrelated to COVID‐19 has been disrupted and will be further affected. Researchers, trial participants and study personnel have to overcome challenges to sustain proper and safe conduct of clinical trials (i.e. logistical challenges, lower enrollment than expected, difficulties in follow‐up and outcome assessment/adjudication, incomplete data collection, research funding prolongation).

Ejemplares similares